Health Economics

Brent C. James, MD, MStat, Executive Director and Quality Officer, Intermountain Health­care Leadership Institute, Salt Lake City, UT delivered the Presidential lecture at the 2016 American Academy of Neurology annual meeting.
Read More

A cost-effectiveness analysis of relapsing-remitting multiple sclerosis (MS) therapies has shown the importance of using first-line treatments first to treat the disease. In terms of achieving no evidence of disease activity (NEDA), the most effective treatment strategy was natalizumab in the first-line setting, followed by alemtuzumab as first-line treatment, according to a presentation at the 2016 American Academy of Neurology annual meeting.

Read More

Neurologist-directed ambulatory care for chronic neurologic diseases resulted in higher costs but fewer adverse events and less use of acute care services, according to an American Academy of Neurology–supported study.
Read More

A model study estimating the potential impact of increased use of sodium channel blockers (SCBs) among patients with partial-onset seizures suggests significant reductions in costs, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

Two cross-sectional studies of the decision-making process, insurance coverage and disease-modifying therapy (DMT) choices of patients with multiple sclerosis, provide glimpses of patients’ preferences.
Read More

Patients with secondary-progressive multiple sclerosis (SPMS) have to endure more than just declining physical and cognitive function.
Read More

In the year following a relapse, patients with multiple sclerosis remained less productive and their health deteriorated further compared with patients with multiple sclerosis whose disease had not relapsed, according to analyses presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

Clinical and in-hospital process variables are associated with hospital length of stay (LOS) in acute ischemic stroke patients, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

The costs for inpatient care are significantly affected by the age and sex of patients with multiple sclerosis (MS) who experience disease relapse, according to data presented at the 2015 annual meeting of the American Academy of Neurology.
Read More

Philadelphia, PA—Neurologists are amidst a social transformation that threatens their professionalism, their ethical foundation, and their patients, said James L. Bernat, MD, Professor of Neurology and of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Read More

Page 1 of 2

Subscribe to
Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to recieve the free VBCN e‑Newsletter.

I'd like to recieve: